Women's health care nurse practitioners make decisions across routine visits, reproductive care, pregnancy, and postpartum follow-up. A useful way to study is to connect each finding to the decision it changes: what the history makes more likely, what a test can establish, and when a patient needs urgent evaluation or collaborative care. This guide builds from assessment through primary care and gynecologic problems, then follows pregnancy into postpartum care. It also examines how drug behavior changes with physiology and how consent, confidentiality, documentation, and evidence shape practice. The cases are designed to make you interpret several facts together, including chronology and competing explanations, while staying within the WHNP role and the applicable practice setting.
Assessment, Diagnostic Testing and Interpretation
1. Build a history that changes the differential
A useful history asks what happened, when it happened, and what could change the meaning of the symptom. For bleeding, establish the last normal period, onset, amount, pain, and whether the blood seems vaginal, urinary, or rectal. Ask about pregnancy possibility before assuming a menstrual or medication cause. Reconcile the actual contraceptive schedule, missed doses, other medicines, and recent changes; the prescription list alone cannot show how a method was used. Sexual practices and exposure sites guide infection testing, while prior pregnancies, procedures, and family history may change concern for structural disease or inherited risk. The WHNP-BC candidate guide includes these history and assessment topics. Finish by identifying instability or severe pain that changes the urgency of examination.
Worked example: A patient reports spotting for five days after missing two combined pills and having sex without a barrier method. The missed pills make withdrawal bleeding plausible, but also weaken pregnancy protection. Clarify the dates of missed pills, sex, and bleeding; assess pain and bleeding severity; and obtain an appropriately timed pregnancy test. If an early test is negative, plan repeat testing when it can reliably detect that exposure.
Watch the distinction: Calling the spotting a pill side effect closes the differential too early. Missed pills and unprotected sex make pregnancy assessment necessary even when the bleeding looks familiar.
Reference: [1]
2. Match the examination to the complaint
Choose examination elements that answer the presenting question while checking for danger first. General appearance, vital signs, and mental status indicate whether a patient can tolerate a routine office evaluation. With pelvic pain, assess abdominal tenderness, guarding, and distension, then consider pelvic examination when appropriate to evaluate bleeding, discharge, cervical findings, or adnexal tenderness. Breast symptoms call for inspection and a focused breast and regional node examination. Reproductive care may also require a focused male genital examination, based on the patient's anatomy and complaint. A finding gains meaning from its context: unilateral tenderness with sudden onset differs from mild recurrent discomfort. If dizziness, fainting, marked guarding, or suspected pregnancy accompanies acute pain, prioritize stabilization and urgent evaluation over completing every routine examination component.
Worked example: A patient develops abrupt right pelvic pain and vomiting, then feels dizzy while standing. Examination shows guarding and a rapid pulse. Assess circulation, obtain pregnancy status, and arrange urgent evaluation for conditions such as ectopic pregnancy, torsion, or intra-abdominal bleeding. A detailed routine pelvic follow-up next week would delay care; a negative pregnancy test would narrow, but not eliminate, the urgent differential.
Watch the distinction: A pelvic examination alone cannot establish the cause of acute unilateral pain. Guarding and dizziness require an assessment of stability and pregnancy before routine follow-up is considered.
Reference: [1]
3. Interpret anemia patterns
Read anemia studies as a pattern, starting with hemoglobin to identify reduced oxygen-carrying capacity and mean corpuscular volume to describe average cell size. Microcytosis suggests impaired hemoglobin production; low ferritin supports depleted iron stores, often after sustained blood loss. Ferritin can rise during inflammation, so a value within the laboratory range does not always exclude iron deficiency when inflammatory disease is present. Marked microcytosis with relatively preserved red-cell count or an unrevealing iron evaluation raises a hemoglobinopathy question. Hemoglobin testing can identify some inherited variants, although iron deficiency may complicate interpretation of certain results. Macrocytosis points elsewhere, including folate deficiency. Relate the pattern to menstrual blood loss, diet, pregnancy context, and family history, then investigate the source of loss rather than treating a laboratory label alone.
Worked example: A patient with months of heavy menses has hemoglobin 10 g/dL, mean corpuscular volume 70 fL, and ferritin 8 ng/mL, reported below this laboratory's range. The low hemoglobin establishes anemia; small cells and depleted iron stores favor iron deficiency from blood loss. Address the bleeding source and iron replacement. If ferritin were normal with persistent marked microcytosis, revisit inflammation and inherited hemoglobin conditions.
Watch the distinction: Low mean corpuscular volume does not prove iron deficiency by itself. A thalassemia trait can also produce small cells, and ferritin needs interpretation alongside inflammation and history.
Reference: [1]
4. Choose metabolic and urine tests
Select laboratory tests according to the mechanism being investigated. Frequent urination may reflect an increased volume of glucose-rich urine from hyperglycemia, small frequent voids from bladder irritation, or both. Blood glucose assesses systemic glycemia; urine glucose reflects glucose spilling through the kidneys and cannot independently diagnose diabetes. Urinalysis can reveal white cells, blood, glucose, or protein, but each finding needs clinical context. A compatible urine culture identifies an organism when infection is suspected and can guide treatment decisions. Kidney function tests help interpret renal involvement and medication safety, while a urine protein-to-creatinine ratio estimates protein loss relative to urine concentration. Thyroid testing is useful when fatigue, bowel changes, temperature intolerance, or cycle changes suggest endocrine disease. First define the question, then interpret concordant and discordant findings.
Worked example: One patient reports large-volume urination and thirst without burning. Urine contains glucose, and blood glucose is elevated, so assess hyperglycemia rather than labeling a urinary infection. Another has burning, urgency, white cells in urine, and growth of a compatible organism on culture. That pattern supports infection. If the second patient also develops fever and flank pain, evaluate possible upper tract disease.
Watch the distinction: Urinary frequency is a symptom, not a diagnosis. Treating every frequent void as cystitis overlooks osmotic diuresis from hyperglycemia and may lead to an unnecessary antibiotic.
Reference: [1]
5. Interpret genital and STI specimens
A specimen answers only the question its method and collection site allow. Vaginal pH and wet microscopy help characterize a local discharge: clue cells support bacterial vaginosis, yeast forms support candidiasis, and motile trichomonads may be seen when present. Microscopy can miss infection, so a negative slide does not settle every case. Nucleic acid amplification tests detect selected organism genetic material with high sensitivity, but the result applies to the sampled anatomic site and the organisms on that assay. Culture remains useful when organism growth or susceptibility information is needed. Ask about oral, genital, and rectal exposure privately, then match collection sites to exposure and symptoms. Interpret results alongside examination and pretest probability; no test replaces a coherent clinical picture.
Worked example: A patient has thin discharge and odor. Vaginal pH is elevated and microscopy shows clue cells, supporting bacterial vaginosis. The patient also reports recent oral exposure and throat discomfort. A negative vaginal chlamydia and gonorrhea nucleic acid test does not assess the throat. Collect a throat specimen if indicated by exposure and symptoms, using an appropriate validated assay.
Watch the distinction: A negative genital STI test cannot clear every exposed site. Specimen location matters as much as test sensitivity, and a vaginal result says nothing directly about pharyngeal infection.
Reference: [1]
6. Use imaging and biopsy for different questions
Imaging describes structures; tissue sampling evaluates cells. Pelvic ultrasonography can show endometrial thickness, a focal lesion, fibroid position, or an adnexal mass, helping locate a likely source of symptoms and plan the next step. It cannot determine whether an abnormal area is hyperplasia or cancer merely from its appearance. Likewise, mammography and targeted breast imaging can localize and characterize a finding, while biopsy addresses uncertain tissue diagnosis. Consider how well a test samples the suspected area: a focal lesion may require directed assessment if a blind sample misses it. A reassuring image also has limits when bleeding persists or risk factors remain. Select the test by the unresolved clinical question, and use symptom course and patient risk to decide whether histology is still needed.
Worked example: A patient with repeated unpredictable bleeding has an ultrasound showing a focal endometrial lesion. The image supports a structural cause but cannot classify its cells. Because bleeding persists, arrange an appropriate endometrial evaluation, potentially with directed sampling. If pathology identifies a benign polyp, the structural finding and tissue result can be interpreted together; the image alone could not provide that conclusion.
Watch the distinction: A well-defined lesion on ultrasound is not automatically benign. Imaging can describe its size and location, but concerning or persistent bleeding may still require tissue assessment.
Reference: [1]
7. Explain genetic test results
Keep three genetic questions separate. Family history estimates inherited risk but can miss a variant when families are small, relatives are young, or information is incomplete. Carrier screening asks whether a person carries a variant that could affect offspring, often without causing that person disease. Diagnostic testing asks whether a defined variant or condition is present in the tested individual. When a relative has a known pathogenic variant, targeted testing for that variant is more informative than a vague statement that the family history is negative. A positive result may change surveillance or reproductive choices; a negative result has different meaning depending on whether the familial variant was known and tested. Explain residual risk, possible uncertain results, and implications for relatives before and after testing.
Worked example: A patient's sibling has a documented pathogenic hereditary cancer variant. The patient reports no other affected relatives and assumes that means no inherited risk. Review the sibling's exact result and offer genetics referral for targeted counseling and testing. A negative result for that familial variant would be more informative than an unspecified broad negative panel; either result needs interpretation in the family context.
Watch the distinction: An apparently quiet family history does not erase a documented familial variant. Family size, ages, and missing records can hide a pattern, so the known variant deserves specific attention.
Reference: [1]
Primary Care
8. Assess cardiovascular risk and urgent symptoms
Cardiovascular assessment combines long-term risk with recognition of immediate threats. Repeated blood-pressure readings, obtained with suitable technique, better describe sustained hypertension than one isolated clinic value. Lipids, diabetes, tobacco exposure, family history, and reproductive plans influence prevention and treatment choices. Acute symptoms require a separate decision: unilateral leg swelling can indicate venous thrombosis, while sudden breathlessness, chest discomfort, fainting, or low oxygenation raises concern for pulmonary embolism. Ask about onset, immobilization, pregnancy or postpartum status, and estrogen exposure without letting any one factor rule disease in or out. First assess stability and arrange emergency evaluation when a clot is plausible; address chronic blood-pressure and lipid risk after the acute threat is handled. The family nurse practitioner certification guide offers related primary care review.
Worked example: A patient has a mildly elevated clinic blood-pressure reading and a swollen, painful left calf. During the visit, breathlessness begins abruptly. The blood-pressure reading cannot explain the symptom sequence. Assess vital signs and oxygenation, then arrange emergency evaluation for possible pulmonary embolism. Once the acute concern is resolved, confirm whether blood pressure remains elevated across properly obtained readings.
Watch the distinction: Anchoring on a familiar chronic risk can obscure an emergency. A modestly elevated blood pressure does not account for unilateral leg swelling followed by sudden breathlessness.
Reference: [1]
9. Recognize diabetes and thyroid disease
Diabetes and thyroid disease often share nonspecific complaints, so look for clusters and mechanisms. Hyperglycemia can exceed renal glucose handling, drawing water into urine and causing polyuria and thirst. Diabetes also affects infection risk, pregnancy planning, and vascular health. Reduced thyroid hormone action slows gastrointestinal activity and often produces cold intolerance, constipation, fatigue, dry skin, and cycle changes. Excess thyroid hormone more often produces heat intolerance, palpitations, tremor, and altered bleeding patterns. Pregnancy, medications, anemia, and mood disorders may mimic parts of either picture. Choose blood glucose assessment when osmotic symptoms predominate and thyroid testing when the symptom pattern supports it; both may be needed. Interpret results against the clinical history, repeat or confirm unexpected findings as appropriate, and connect any diagnosis to reproductive goals.
Worked example: A patient reports fatigue, constipation, feeling cold, and less predictable periods, without thirst or increased urine volume. Thyroid assessment is a focused first step, alongside pregnancy assessment if relevant. If a second patient instead reports persistent thirst, large urine volumes, and recurrent genital yeast symptoms, prioritize glucose evaluation. Neither symptom cluster alone establishes a diagnosis.
Watch the distinction: Fatigue alone is too broad to label a thyroid disorder. The associated bowel, temperature, urinary, menstrual, and medication history determines which tests are likely to answer the question.
Reference: [1]
10. Localize urinary symptoms
Localize urinary complaints by combining pain location, systemic features, and urine findings. Cystitis commonly causes dysuria, urgency, frequency, and suprapubic discomfort without flank pain or systemic illness. Pyelonephritis suggests infection involving the kidney and becomes more likely with fever, flank tenderness, nausea, or vomiting. A stone may cause abrupt colicky flank pain radiating toward the groin, sometimes with blood in urine; infection can coexist and makes obstruction more dangerous. Urethritis or genital inflammation can produce burning with a different exposure and examination pattern. Persistent frequency without infection may reflect urgency incontinence or another noninfectious cause. Pregnancy status, ability to take fluids and medicines, severity of illness, and possible obstruction affect urgency. Use urinalysis and culture when they can distinguish these pathways, then reassess if symptoms and results conflict.
Worked example: A patient has two days of dysuria and frequency, is drinking normally, and has no fever or flank pain. Lower tract infection is plausible after focused assessment. Another patient has the same urinary symptoms plus fever, right flank pain, and vomiting. That combination raises concern for pyelonephritis and dehydration, requiring prompt evaluation rather than routine lower tract treatment.
Watch the distinction: A positive urine dipstick does not make every urinary illness uncomplicated cystitis. Fever, flank pain, vomiting, or possible obstruction changes both the differential and urgency.
Reference: [1]
11. Separate common gastrointestinal problems
Gastrointestinal symptoms become clearer when tied to location, timing, bowel pattern, and alarm features. Burning behind the sternum after meals may fit reflux, particularly when associated with regurgitation, but chest pain with concerning cardiopulmonary features needs urgent assessment. Constipation describes difficult or infrequent passage and may contribute to fissures or hemorrhoids. Bright-red blood limited to wiping after a hard stool suggests a distal anal source, especially if pain or a visible lesion is present. It still requires attention to duration, amount, change in bowel habits, weight loss, family risk, and anemia. Bleeding mixed with stool or persistent unexplained bleeding broadens concern beyond a local anal lesion. Examine appropriately, address reversible contributors, and arrange further evaluation when the symptom course or risk profile does not fit a benign explanation.
Worked example: A patient strains with hard stools and notices a small streak of bright-red blood on the paper with sharp anal pain. A fissure is plausible on examination, so treat constipation and the local lesion. If bleeding continues after stools soften or a blood count shows anemia, investigate another source rather than repeatedly attributing blood loss to constipation.
Watch the distinction: Finding hemorrhoids does not prove they cause all rectal bleeding. Persistent bleeding, anemia, or changed bowel habits warrants evaluation even when an anal source is visible.
Reference: [1]
12. Evaluate respiratory and HEENT complaints
Respiratory and upper airway assessment starts with work of breathing, oxygenation, and ability to speak. Nasal congestion, sore throat, and cough with comfortable breathing and clear lungs often suggest an upper airway illness, although duration and focal findings may change the differential. Asthma involves variable airway narrowing and inflammation; wheeze may be present, but severe airflow limitation can produce little audible wheeze. Ask about triggers, prior attacks, current reliever use, and response to treatment. Increased respiratory effort, inability to finish sentences, altered alertness, or falling oxygenation calls for urgent assessment. Ear or sinus pain, fever, and unilateral findings may redirect a focused HEENT examination. Choose management from the severity and likely site of disease rather than prescribing from the word 'cough' alone.
Worked example: One patient has nasal congestion and sore throat, speaks comfortably, and has clear breath sounds without shortness of breath. Focus on upper airway findings and supportive care. Another has audible wheeze, uses accessory muscles, and pauses after a few words. Assess oxygenation and airflow promptly, initiate appropriate acute care, and escalate if breathing does not improve.
Watch the distinction: The presence or absence of wheeze alone does not grade asthma severity. Work of breathing, speech, mental status, and oxygenation carry more immediate safety information.
Reference: [1]
13. Identify skin and musculoskeletal warning signs
Skin and musculoskeletal complaints need a timeline and a search for warning signs. An itchy rash after a new topical product, limited to contact areas, supports contact dermatitis; scale, distribution, and exposure history may instead suggest eczema, psoriasis, or fungal infection. A changing pigmented lesion needs assessment of evolution, asymmetry, border, color, and symptoms, with referral or biopsy when concerning. For pain, a mechanical strain often follows activity and worsens with movement, while a hot swollen joint, fever, prolonged morning stiffness, or multiple inflamed joints suggests infection or systemic inflammatory disease. Examine the whole relevant area rather than treating a label supplied by the patient. Steroids can mask infection or alter a lesion, so establish the likely cause before empiric treatment.
Worked example: A patient develops itchy patches in both elbow creases after changing a skin product, but also points to a dark shoulder spot that has enlarged and changed color over months. The rash may be contact dermatitis; stop the suspected exposure and assess it separately. Examine and document the pigmented lesion, then arrange appropriate lesion evaluation instead of applying the same steroid treatment to both.
Watch the distinction: One visit can contain two unrelated problems. A plausible dermatitis does not explain a changing pigmented lesion, and treating both with a steroid can delay diagnosis.
Reference: [1]
14. Assess headache, mood, and safety
Headache assessment first separates a familiar pattern from a new neurologic threat. Ask about speed of onset, maximal intensity, neurologic symptoms, fever, trauma, pregnancy or postpartum status, medicines, and substance use. A recurrent episodic headache with similar triggers and no new deficits may fit a primary headache disorder. Sudden severe onset, weakness, confusion, seizure, or a major change in pattern demands urgent assessment even in someone with migraine. Mood and safety belong in the same clinical encounter: ask privately about depression, anxiety, self-harm, substance use, and violence when cues arise. A private conversation improves disclosure, but confidentiality and consent duties depend on the patient's jurisdiction and circumstances. Prioritize immediate neurologic or personal safety risks, then plan follow-up for chronic symptoms.
Worked example: A patient with years of migraine reports a headache that reached peak intensity suddenly and now has left arm weakness. The old diagnosis cannot account safely for the new pattern. Perform a rapid neurologic and stability assessment and arrange emergency evaluation. At a later safe point, review headache control, mood, substance use, and home safety privately.
Watch the distinction: A history of migraine does not make every later headache a migraine. Abrupt onset with a focal deficit is a new presentation that requires urgent evaluation.
Reference: [1]
15. Make prevention specific to risk
Prevention works best when linked to the patient's risks and goals. First identify reproductive plans, tobacco and alcohol use, activity, nutrition, medications, family history, and prior screening. Then match cancer, cardiovascular, diabetes, bone-health, and immunization decisions to age, history, anatomy, and applicable guidance without assuming one schedule fits everyone. Preconception care adds review of chronic conditions, potentially harmful exposures, and medicine safety before pregnancy is possible. Weight and exercise counseling should name a feasible change and a way to revisit it. Screening is not a substitute for evaluating symptoms: a patient with new bleeding or a breast mass needs diagnostic assessment even if routine screening is current. Ask which goal matters most to the patient and make a follow-up plan that measures progress.
Worked example: A patient hopes to conceive within several months, smokes daily, and takes a long-term medicine for a chronic condition. Review the medicine's indication and pregnancy evidence with the treating team, offer specific cessation support, and assess disease control before conception. Also check relevant immunizations and screening history. A generic wellness handout would miss the exposure and medication decisions that matter now.
Watch the distinction: Current screening does not settle a new symptom, and preconception counseling is more than recommending a supplement. Tobacco, chronic disease, and medication exposure may need action before pregnancy.
Reference: [1]
Gynecologic and Reproductive Health
16. Trace the reproductive hormone cycle
The menstrual cycle reflects coordinated signals from hypothalamus, pituitary, ovary, and endometrium. Pulsatile hypothalamic signaling prompts pituitary follicle-stimulating and luteinizing hormones. Developing follicles make estradiol, which builds the endometrium. A sustained estradiol signal helps trigger the luteinizing hormone surge and ovulation. The corpus luteum then makes progesterone, converting the endometrium into a secretory lining. If pregnancy does not sustain luteal function, progesterone and estrogen fall and the lining sheds. Without ovulation, there is no predictable luteal progesterone phase. Estrogen may still stimulate growth, producing irregular, sometimes heavy shedding. This mechanism explains why a delayed period does not always mean a uniformly 'thin' lining. Use cycle history, pregnancy status, and endocrine clues to distinguish anovulation from other causes of bleeding.
Worked example: A patient has cycles that vary widely and then develops several days of unpredictable bleeding. Pregnancy testing is negative, and the history suggests missed ovulation. Without a regular corpus luteum, progesterone exposure is inconsistent while estrogen may continue to stimulate the endometrium. Irregular shedding follows. If this pattern persists, assess the cause of anovulation and whether the lining needs evaluation.
Watch the distinction: Anovulation does not mean ovarian hormones stop completely. Ongoing estrogen without predictable progesterone can produce irregular bleeding and prolonged endometrial stimulation.
Reference: [1]
17. Classify amenorrhea before testing
Classify absent menses by whether menstruation has ever occurred. Primary amenorrhea prompts attention to pubertal development, reproductive anatomy, chromosomal or gonadal conditions, and endocrine signaling. Secondary amenorrhea follows established cycles and has a different starting differential. In anyone with pregnancy potential, test for pregnancy early because it changes the meaning of every later result. Next examine medications, weight or exercise change, stress, chronic illness, and symptoms such as galactorrhea, hot flashes, or androgen excess. Galactorrhea raises a prolactin question, including medication effects; thyroid disease can also disrupt cycles. Pelvic anatomy matters when cyclic pain occurs without visible bleeding, suggesting possible outflow obstruction. Select hormone and imaging tests to answer the leading questions rather than ordering an undirected panel.
Worked example: A patient who previously menstruated regularly reports three missed expected periods and new milky nipple discharge. First assess pregnancy possibility and test appropriately. If pregnancy is excluded, review medicines that can raise prolactin, examine for other endocrine clues, and evaluate prolactin and thyroid function as indicated. The galactorrhea directs the workup; it does not establish a pituitary diagnosis on its own.
Watch the distinction: Skipping pregnancy testing because galactorrhea suggests prolactin is a tempting shortcut. Pregnancy itself can explain both missed menses and breast changes and should be assessed first.
Reference: [1]
18. Work through abnormal uterine bleeding
Abnormal uterine bleeding requires two linked decisions: whether the patient is stable now and why the bleeding is occurring. Ask about volume, duration, cycle regularity, pain, pregnancy possibility, medicines, and symptoms of anemia. Dizziness, fainting, or signs of poor perfusion move assessment toward urgent stabilization and blood loss evaluation. After pregnancy-related causes are addressed, consider structural causes such as polyps and fibroids, ovulatory dysfunction, endometrial disease, and systemic or medication-related contributors. Ultrasound helps describe anatomy; sampling answers whether concerning endometrial tissue changes are present. Chronic anovulation can leave the endometrium exposed to estrogen without regular progesterone, increasing concern when bleeding is persistent or unpredictable. Apply this decision order when working through WHNP-BC practice questions: stability and pregnancy status come before naming a benign cause.
Worked example: A patient has heavy, irregular bleeding and becomes dizzy on standing. Assess vital signs, perfusion, pregnancy status, and blood loss urgently. Once stable, the history of long gaps between periods suggests anovulation, but a structural lesion remains possible. Imaging can assess the cavity, and persistent irregular bleeding with prolonged estrogen exposure raises the question of endometrial tissue evaluation.
Watch the distinction: Labeling heavy bleeding as a hormone problem before checking stability can miss clinically important blood loss. Anovulation may explain the pattern, but it does not exclude structural or endometrial disease.
Reference: [1]
19. Distinguish causes of painful menses
Painful menses can arise from prostaglandin-driven uterine contractions or from underlying pelvic disease. Primary dysmenorrhea usually begins around established ovulatory cycles, peaks near menstrual onset, and lacks progressive nonmenstrual symptoms. Endometriosis can cause worsening cyclic pain, deep pain with intercourse, bowel or bladder pain tied to menses, and fertility difficulty; examination may be normal. Adenomyosis involves endometrial-type tissue within uterine muscle and may combine painful, heavy periods with an enlarged or tender uterus. History should capture onset, progression, timing through the cycle, bleeding amount, sexual pain, bowel symptoms, and prior treatment response. Pregnancy-related or acute causes need consideration when pain is new or atypical. Imaging may identify adenomyosis or other structural disease, while a normal scan does not rule out endometriosis.
Worked example: A patient reports menstrual cramps that have worsened over two years and now has deep pain with intercourse and pain during bowel movements near each period. That progression and symptom combination favors evaluation for endometriosis over assuming uncomplicated primary dysmenorrhea. Ask about fertility goals, examine for alternative causes, and discuss appropriate symptom treatment and further assessment.
Watch the distinction: A normal pelvic ultrasound does not exclude endometriosis. Symptoms can arise from deposits too small or situated poorly for routine imaging to identify.
Reference: [1]
20. Recognize uterine structural disease
Leiomyomas and polyps are both structural findings, but location determines their likely effects. A fibroid is a benign smooth-muscle tumor; one that projects into or distorts the uterine cavity can increase bleeding and interfere with implantation, while an outer-surface fibroid may produce pressure with little bleeding. An endometrial polyp is a focal growth of the uterine lining and may cause irregular or intermenstrual bleeding. A cervical polyp may be visible at the cervix and can bleed after contact. Ultrasonography helps define size and position, though direct cavity assessment or tissue sampling may be needed to characterize a focal lesion. Avoid assuming every finding causes the patient's symptom: match location, timing, and examination to the complaint, and consider tissue evaluation when bleeding risk or persistence warrants it.
Worked example: A patient has heavy periods and difficulty conceiving. Imaging shows a fibroid deforming the uterine cavity plus a separate focal endometrial lesion. The cavity-distorting fibroid could contribute to both concerns, but the focal lesion may be a polyp and needs its own assessment. Review each lesion's location and the bleeding history before planning treatment or attributing every symptom to the fibroid.
Watch the distinction: The mere presence of a fibroid does not prove it explains bleeding or infertility. Its position matters, and a separate focal lesion cannot be assumed to be another fibroid.
Reference: [1]
21. Evaluate polycystic ovary syndrome
Polycystic ovary syndrome involves disrupted ovulation and excess androgen activity, often alongside insulin resistance. The resulting menstrual pattern may be infrequent or unpredictable, while androgen effects can appear as hirsutism or acne. In adults, a compatible combination of ovulatory dysfunction, clinical or biochemical androgen excess, and characteristic ovarian appearance supports diagnosis after other causes are considered; an ultrasound finding alone is insufficient. First establish pregnancy status when periods are missed. Then assess the onset and pace of symptoms, medication use, weight changes, and signs suggesting thyroid disease, elevated prolactin, or another androgen source. Metabolic assessment matters because glucose and lipid abnormalities affect long-term health. Repeated anovulation also means the endometrium may receive prolonged estrogen stimulation without predictable progesterone exposure, so bleeding patterns need attention. The WHNP-BC candidate guide includes this disorder within gynecologic care.
Worked example: A 26-year-old reports increasingly irregular periods over two years, gradual chin hair growth, and a history of elevated glucose. A pregnancy test is negative. This pattern supports evaluation for polycystic ovary syndrome, including androgen and metabolic findings and exclusion of mimicking endocrine disorders. If facial hair and voice changes had appeared rapidly over weeks, assessment for another androgen source would take priority.
Watch the distinction: Do not diagnose polycystic ovary syndrome from a scan showing multiple follicles. Ovarian appearance must be interpreted with the menstrual and androgen history and possible alternative causes.
Reference: [1]
22. Triage an adnexal mass
An adnexal mass may arise from the ovary, fallopian tube, or nearby structures. Start with pregnancy status and immediate stability, then ask whether pain began suddenly or developed gradually. Sudden unilateral pain with nausea or vomiting raises concern for ovarian torsion, in which twisting can impair venous drainage and eventually arterial supply. Pregnancy-related pain also requires assessment for ectopic pregnancy. Ultrasound helps describe size, internal complexity, solid areas, and fluid, but reassuring Doppler flow does not by itself exclude intermittent torsion. A simple-appearing cyst in a stable patient with mild symptoms may permit planned follow-up, guided by age, symptoms, imaging, and reproductive goals. A complex or persistent mass needs a different assessment for neoplasm or other disease. Analgesic response does not establish that the mass is harmless.
Worked example: A patient with a known right adnexal mass develops abrupt right-sided pain and vomits twice. Her pregnancy test is negative, and she remains uncomfortable between pain surges. Urgent evaluation for torsion is appropriate even if ultrasound detects some ovarian blood flow. By comparison, a stable patient with slowly developing mild discomfort and a simple-appearing cyst can undergo risk-based follow-up.
Watch the distinction: A negative pregnancy test narrows the emergency differential but does not make sudden adnexal pain routine. Torsion can occur without pregnancy and may threaten ovarian tissue.
Reference: [1]
23. Differentiate causes of vaginitis
Vaginal symptoms overlap, so use discharge, irritation, examination, pH, and microscopy together. Candidiasis commonly causes prominent itching and vulvar inflammation; microscopy may show budding yeast or hyphae, while vaginal pH often remains in its usual acidic range. Bacterial vaginosis reflects a shift in the vaginal bacterial community and commonly produces thin discharge, odor, elevated pH, and clue cells. Trichomoniasis is a sexually transmitted infection that may cause irritation and elevated pH, but symptoms can be subtle. Microscopy can miss trichomonads, so a nucleic acid test is useful when exposure or findings sustain suspicion. Ask about pregnancy possibility, recent antimicrobial use, products applied to the vulva, and STI exposure. A negative wet mount should be interpreted in light of its limited sensitivity and the quality of the specimen.
Worked example: Two patients describe discharge. One has intense itching, vulvar redness, an acidic vaginal pH, and yeast forms on microscopy, supporting candidiasis. The other reports fishy odor; her sample has elevated pH and clue cells, supporting bacterial vaginosis. If the second patient also reports a new partner, assess STI exposure separately rather than assuming the vaginal microscopy answers every question.
Watch the distinction: Elevated vaginal pH does not uniquely identify bacterial vaginosis. Trichomoniasis and other factors can alter pH, so combine it with symptoms, microscopy, and indicated infection testing.
Reference: [1]
24. Recognize cervicitis and pelvic infection
Cervicitis may present with discharge or bleeding after contact, yet infection can also be minimally symptomatic. Pelvic inflammatory disease becomes a concern when infection may have ascended into the uterus, tubes, or surrounding tissues. New pelvic pain, cervical motion or uterine or adnexal tenderness, and STI exposure strengthen suspicion, although no single finding proves it. Check pregnancy status because ectopic pregnancy can also cause pelvic pain. Choose nucleic acid testing from the sites actually exposed, such as genital, rectal, or pharyngeal sites when relevant. A positive test helps identify an organism, but a pending or negative cervical result does not exclude an upper genital tract process. Timely clinical management matters because delayed treatment can increase risks of infertility, ectopic pregnancy, and chronic pain. Assess severity and need for urgent referral or collaboration.
Worked example: A 24-year-old has three days of lower abdominal pain, cervical motion tenderness, and recent unprotected sex with a new partner. She has no confirmed infection result yet. Obtain a pregnancy test and site-appropriate STI specimens, assess illness severity, and arrange prompt care for suspected pelvic inflammatory disease. Waiting for every laboratory result could delay treatment of a clinically concerning ascending infection.
Watch the distinction: Do not rule out pelvic inflammatory disease because the cervix looks only mildly inflamed. Upper tract infection is a clinical concern that cannot be dismissed by one cervical finding.
Reference: [1]
25. Build a pelvic pain differential
Pelvic pain requires a location and time course before a label. First assess vital signs, pregnancy possibility, bleeding, and signs of peritoneal irritation or instability. Sudden pain can signal ectopic pregnancy, torsion, cyst rupture, or a nongynecologic emergency; a cyclic pattern may suggest dysmenorrhea or endometriosis. Ask how pain relates to menses, intercourse, urination, and bowel movements, then examine the abdomen and pelvis as indicated. Fever and tenderness raise concern for infection, while urinary symptoms or altered bowel habits shift the differential toward those organ systems. A positive pregnancy test with pain is especially consequential because location remains unknown until assessed. Imaging and laboratory tests should answer the leading clinical questions rather than serve as an undirected panel. Recurrent pain still deserves reassessment when its pattern changes.
Worked example: One patient has months of pain during menses and bowel movements but is stable today; endometriosis is among the possibilities for planned evaluation. Another has sudden unilateral pain, vaginal spotting, dizziness, and a positive pregnancy test. Her pregnancy location is unknown, so assess stability and arrange urgent evaluation for possible ectopic pregnancy rather than attributing the pain to a menstrual condition.
Watch the distinction: A history of chronic cyclic pain cannot explain every new episode. Sudden onset, dizziness, bleeding, or a positive pregnancy test changes the priority immediately.
Reference: [1]
26. Assess vulvar and gland lesions
A Bartholin gland duct obstruction can form a cyst near the posterior vaginal opening. When infection develops, increasing tenderness, warmth, and fluctuance may indicate an abscess. Its position and acute course help distinguish it from a more diffuse vulvar rash. Dermatoses such as lichen sclerosus can cause itching, fragile skin, and white plaques; persistent architectural change or a focal abnormal area deserves careful examination. A lesion that is persistent, atypical, ulcerated, pigmented, or otherwise suspicious may need tissue diagnosis. Ask about fever, walking or sitting pain, recurrent episodes, and effects of irritants or topical products. Examination should describe exact site, surface, size, tenderness, and whether the lesion is cystic or solid. Do not assume every unilateral gland-region mass is benign, particularly when its appearance or patient context is concerning.
Worked example: A patient has a rapidly enlarging, fluctuant swelling beside the vaginal opening, marked pain when sitting, and fever. The findings support urgent assessment of a Bartholin gland abscess and associated illness. A second patient has months of itching and a persistent white plaque without a fluctuant mass. That pattern calls for evaluation of vulvar dermatosis and whether biopsy is needed.
Watch the distinction: Repeated empiric treatment for presumed yeast can delay diagnosis of a persistent vulvar plaque. A localized skin change needs direct examination and, when indicated, tissue assessment.
Reference: [1]
27. Interpret gynecologic cancer warning signs
Cancer warning signs are tied to the affected tissue, so a normal test at one site does not clear another. Bleeding after established menopause raises an endometrial question; cervical cytology screens for cervical cellular change and cannot assess the uterine lining. Bleeding after intercourse or a visible cervical lesion calls for cervical evaluation even when a prior screening test was normal. Persistent bloating, early satiety, pelvic pressure, or an adnexal mass can prompt ovarian assessment, although these symptoms are nonspecific. A persistent vulvar ulcer, plaque, or changing lesion may require biopsy. Ask about symptom duration, bleeding pattern, medications, family history, and relevant inherited cancer risk. Use examination, imaging, and tissue sampling for their different purposes: imaging describes anatomy, whereas pathology identifies cellular disease. Escalate promptly when bleeding, examination, or systemic findings are concerning.
Worked example: A 58-year-old whose menstrual periods ended years ago reports new vaginal bleeding. Her recent cervical screening result was normal. That result does not assess the endometrium, so evaluate the bleeding source and arrange appropriate uterine lining assessment. If examination instead reveals a visible cervical lesion, that lesion also needs direct evaluation despite the prior screening result.
Watch the distinction: A normal cervical screening result is not a general gynecologic cancer clearance. It cannot establish that the endometrium, ovaries, vulva, or vagina are free of disease.
Reference: [1]
28. Evaluate breast symptoms
For a breast symptom, distinguish a focal change from diffuse cyclic discomfort and ask whether the finding is new, persistent, or linked to lactation. Describe a mass by location, size, mobility, texture, and associated skin or nipple changes; also examine regional nodes. Imaging selection depends on patient context and the clinical finding, and a suspicious examination may still need tissue sampling when imaging is reassuring. Lactational inflammation with focal redness and systemic symptoms follows an infection pathway, while a persistent focal mass needs its own evaluation. Spontaneous unilateral discharge from a single duct, particularly if bloody, is more concerning than bilateral discharge produced only by squeezing. Review medications and pregnancy possibility when discharge suggests a hormonal cause. The breast care guide can complement this focused symptom assessment.
Worked example: A 39-year-old notices spontaneous bloody discharge from one nipple without squeezing it. Examination identifies one affected duct but no clear mass. Arrange focused breast assessment and indicated imaging; the absence of a palpable mass does not settle the cause. In contrast, bilateral milky discharge that occurs only with expression directs the history toward pregnancy, medication, and endocrine possibilities.
Watch the distinction: Do not reassure a patient about spontaneous single-duct bloody discharge solely because no mass is felt. A duct lesion may be too small to palpate.
Reference: [1]
29. Separate prolapse from urinary incontinence types
Urine loss is classified by the event immediately preceding it. Leakage during coughing, lifting, or exercise suggests stress incontinence from inadequate urethral closure during increased abdominal pressure. A sudden compelling urge followed by leakage suggests urgency incontinence, often linked to involuntary bladder contractions. Overflow is more likely when incomplete emptying causes dribbling, weak stream, or a high postvoid residual. These mechanisms can coexist. Pelvic organ prolapse describes descent of supported organs and may cause a bulge, pressure, or altered voiding, but its presence does not identify the leakage mechanism by itself. Ask about fluid intake, medications, childbirth or surgery, bowel symptoms, urinary infection symptoms, and impact on daily life. A focused pelvic examination and selected urine or emptying tests clarify the pattern and guide treatment choices.
Worked example: A patient notices a mild vaginal bulge. She leaks only when coughing and otherwise reaches the toilet without urgency, supporting stress incontinence alongside prolapse. Another patient with the same mild bulge leaks after a sudden urge and reports frequent trips to the toilet, favoring an urgency mechanism. If either reports a weak stream and persistent dribbling, assess emptying as well.
Watch the distinction: Finding prolapse does not mean every urinary symptom comes from poor support. The leakage trigger and evidence of bladder emptying determine which mechanisms need evaluation.
Reference: [1]
30. Manage the menopause transition
As ovarian follicle activity becomes less predictable, ovulation and hormone output vary. Cycle length and flow can fluctuate, and falling estrogen activity contributes to hot flashes and vaginal or urinary discomfort. These patterns can fit the menopause transition, but bleeding still needs its own history: amount, timing, pregnancy possibility when relevant, medication use, and endometrial risk. Bleeding after menopause is established warrants evaluation rather than attribution to a hot flash pattern. Treatment should match the dominant symptom and the patient's preferences. Local therapy may address genitourinary symptoms, while systemic therapy requires review of individual benefits, contraindications, and risk factors. Nonhormonal approaches may suit some patients. For related chronic disease context across later adult life, the adult gerontology primary care guide offers a complementary perspective.
Worked example: A 49-year-old reports variable cycle spacing and hot flashes, with no heavy bleeding or concerning symptoms. Review pregnancy possibility, symptom burden, and treatment preferences. A 61-year-old whose periods ended years earlier reports new spotting. Even if she also has hot flashes, evaluate the bleeding source and endometrium rather than treating the spotting as an expected transition symptom.
Watch the distinction: Hot flashes do not explain all abnormal bleeding. The timing of the last true menstrual period and the new bleeding pattern determine whether a separate evaluation is needed.
Reference: [1]
31. Apply fertility-awareness principles
Pregnancy is most likely when intercourse occurs near ovulation because sperm can remain viable before an egg is released, while the egg remains available for a much shorter time. Fertility awareness methods try to identify that changing window using cycle records, cervical mucus, basal body temperature, or combinations of observations. Clear, stretchy mucus often signals rising fertility before ovulation; a sustained temperature shift is mainly retrospective evidence that ovulation probably occurred. Neither sign gives a guaranteed date. Illness, disrupted sleep, medications, breastfeeding, and naturally variable cycles can complicate interpretation. For pregnancy planning, observations can guide timing while still allowing uncertainty. For pregnancy avoidance, explain that predicted low-fertility days may be wrong when ovulation shifts; the method requires careful use and a plan for days considered fertile.
Worked example: A patient records cycles of 26, 31, and 35 days and asks whether the same calendar dates are safe each month. They are not: variable cycle length makes a fixed predicted ovulation date unreliable. This month she notices clear, stretchy mucus earlier than expected. Treat it as a possible fertility signal, not proof that ovulation has already happened.
Watch the distinction: A positive mucus observation does not confirm ovulation. It can precede ovulation, while a temperature rise usually becomes clear only afterward and can be affected by illness.
Reference: [1]
32. Start an infertility evaluation
Infertility evaluation follows the steps needed for conception: ovulation, sperm availability and function, open tubes, a receptive uterine environment, and appropriately timed exposure. Begin with pregnancy attempts, cycle pattern, intercourse or insemination timing, prior pregnancies, pelvic infection or surgery, medications, and relevant conditions for every contributing partner. Regular bleeding suggests but does not prove ovulation; ovulatory assessment may still be indicated. Semen analysis is an early, direct way to examine a major possible factor, and prior paternity does not guarantee present sperm function. A history of pelvic inflammatory disease raises concern for tubal damage; imaging can assess tubal passage and uterine shape when indicated. Explain that multiple factors can coexist. Choose tests in a logical sequence rather than assigning cause based on the first abnormal or reassuring clue.
Worked example: A couple has tried to conceive for a sustained period. One partner reports predictable cycles but had pelvic inflammatory disease; the other has never had a semen analysis. Evaluate timing and ovulation, obtain a semen assessment, and consider tubal evaluation because of the infection history. Predictable cycles alone neither demonstrate open tubes nor exclude a sperm factor.
Watch the distinction: Do not begin and end the evaluation with the menstruating partner. Fertility depends on both gametes and the reproductive tract, so semen and tubal factors deserve attention.
Reference: [1]
33. Match contraception to the patient
Contraceptive choice starts with pregnancy goals, desired reversibility, bleeding preferences, ability to use a method consistently, and medical conditions. Barriers can reduce STI exposure and provide contraception but depend on use at each encounter. Combined hormonal methods suppress ovulation through estrogen and progestin; estrogen-related risks make them unsuitable for some patients, including those with migraine with aura. Progestin-only methods vary in route and duration and often change bleeding patterns. Intrauterine contraception offers long duration with little ongoing action, while permanent methods require careful counseling about the intention not to restore fertility. Compare how quickly a method can be stopped, likely bleeding effects, procedural needs, and whether the patient wants an option under their direct control. Check current pregnancy possibility and relevant contraindications before initiation. Shared decision-making should make the patient's priorities explicit.
Worked example: A patient with migraine with aura wants reversible contraception and strongly prefers a method requiring little daily attention. Avoid an estrogen-containing option. Discuss a progestin implant and intrauterine options, including insertion preferences and possible bleeding changes. If STI protection also matters, explain that condoms address that separate goal even when another method provides pregnancy prevention.
Watch the distinction: Do not treat the most effective available method as automatically best for every patient. Medical suitability, reversibility, bleeding effects, procedure preferences, and STI goals shape the choice.
Reference: [1]
34. Address emergency contraception and pregnancy options
After unprotected sex, establish when each exposure occurred, whether there was earlier unprotected sex in the same cycle, current pregnancy symptoms, and what outcome the patient wants. Emergency contraception works by preventing pregnancy after a recent exposure, with method suitability depending on timing, patient factors, and access. It does not resolve an already established pregnancy. A pregnancy test taken soon after the event may be negative because detectable hormone has not yet developed, so arrange appropriately timed follow-up testing when pregnancy remains possible. Discuss ongoing contraception if desired, along with STI exposure and care needs. If pregnancy is confirmed or suspected from an earlier exposure, provide neutral, accurate options counseling and assess urgent symptoms such as pain or heavy bleeding. Respect the patient's decisions and apply the relevant local consent and confidentiality rules.
Worked example: A patient presents after unprotected sex two days ago and reports another exposure several weeks earlier, followed by a missed period. First assess pregnancy possibility from the earlier event; a test now may help with that question but cannot exclude pregnancy from the recent exposure. Discuss suitable emergency contraception for the recent event, follow-up testing, STI needs, and the patient's pregnancy goals.
Watch the distinction: One negative test immediately after sex does not rule out pregnancy from that encounter. Interpret testing against the exposure timeline and plan follow-up when detection is still premature.
Reference: [1]
35. Provide inclusive sexual and reproductive care
Effective sexual and reproductive care follows anatomy, exposures, and goals rather than identity labels. Ask which organs are present when relevant, what types of contact occurred, whether pregnancy is possible or desired, and which terms the patient uses for their body and relationships. A person with a cervix may need cervical assessment; a throat or rectum exposed during sex may need site-specific STI testing. Testosterone can suppress bleeding without reliably preventing ovulation, so contraception may still matter when pregnancy is possible. For male patients and partners, reproductive assessment can include genital symptoms, STI exposure, and semen factors. Discuss confidentiality and consent according to the applicable jurisdiction, especially when care involves adolescents or sensitive information. This approach also avoids assuming that all gender-diverse patients want the same treatments or fertility outcomes.
Worked example: A transmasculine patient taking testosterone has a cervix, has receptive vaginal sex with a sperm-producing partner, and wants to avoid pregnancy. Explain that absent periods do not establish infertility, assess pregnancy possibility, and discuss contraception that fits the patient's preferences. Ask about other exposure sites before choosing STI specimens, and offer cervical care based on anatomy and relevant history.
Watch the distinction: Do not use gender identity or testosterone use as a substitute for a pregnancy or STI exposure history. Neither tells you which organs or exposure sites require assessment.
Reference: [1]
Obstetrics
36. Connect placental function to maternal adaptation
The placenta supports exchange of oxygen, nutrients, and waste between maternal and fetal circulations while producing hormones that sustain pregnancy and influence maternal physiology. Maternal blood volume and cardiac output rise to support uteroplacental flow. Plasma volume often expands more than red-cell mass, so measured hemoglobin concentration can fall through dilution. Kidney blood flow and filtration also increase, which can alter interpretation of renal laboratory values. Ventilation changes as respiratory drive rises, while the growing uterus later affects breathing mechanics. These expected adaptations provide context, but symptoms and laboratory patterns still require assessment. Low hemoglobin with small red cells and depleted iron stores suggests iron deficiency rather than dilution alone. Edema, dyspnea, or fatigue should be interpreted alongside onset, severity, vital signs, and examination, because normal adaptation does not exclude disease.
Worked example: A pregnant patient has a lower hemoglobin concentration than before pregnancy but feels well. Her red-cell size is within the laboratory reference range, and iron studies do not show depleted stores. Plasma expansion could contribute to the concentration change. If the red cells were small and ferritin low, iron deficiency would be more likely and would need its own evaluation.
Watch the distinction: Do not label every hemoglobin decrease in pregnancy as iron deficiency or every decrease as harmless dilution. Red-cell indices, iron studies, symptoms, and the overall trend distinguish the possibilities.
Reference: [1]
37. Establish gestational age
Gestational age is the time elapsed from the established pregnancy dating reference, expressed in completed weeks and extra days. Menstrual dating begins with the first day of the last menstrual period, but uncertain dates or variable ovulation can make it less reliable. Early ultrasound uses fetal measurements when dating is most precise and may lead to an adjusted estimated due date under applicable clinical criteria. Once a reliable dating basis is established, carry it forward consistently; later growth measurements answer a growth question and should not casually reset the pregnancy clock. To advance gestational age, add elapsed days and convert each seven days into one week. This matters because interpretation of prenatal screening, fetal growth, and pregnancy complications depends on accurate timing. Record which evidence established dating and whether a discrepancy needs review.
Worked example: On April 1, an early ultrasound establishes gestational age at 10 weeks 4 days. At the April 15 visit, 14 days have passed. Fourteen days equals two weeks, so the pregnancy is 12 weeks 4 days. A later small growth measurement should be assessed against that established age rather than automatically making the pregnancy younger. WHNP-BC practice questions can reinforce this arithmetic.
Watch the distinction: Do not repeatedly revise dating to make each later scan match average size. That can conceal a genuine growth problem and distort the timing of prenatal decisions.
Reference: [1]
38. Build a prenatal risk picture
Prenatal risk assessment combines prior obstetric outcomes, current medical conditions, exposures, family history, and the patient's circumstances and goals. A previous spontaneous preterm birth raises a different question from an indicated early delivery for maternal disease, so clarify the cause and gestational timing. Review hypertension, diabetes, thyroid disease, medications, tobacco or other substances, infection risk, and inherited conditions. Ask about support, safety, barriers to care, and what the patient hopes to know or decide during pregnancy. Establish baseline findings and identify which risks call for additional surveillance, counseling, or collaboration. Risk is dynamic: a normal examination today documents current status but does not erase prior complications or future changes. Reassess symptoms, laboratory results, fetal findings, and treatment adherence over time, explaining the purpose of any added monitoring.
Worked example: A patient reports a prior spontaneous preterm birth, continues to smoke, and has recently been diagnosed with a chronic thyroid condition. Today her vital signs and examination are reassuring. Clarify the prior birth history, review thyroid treatment and control, offer tobacco cessation support, and plan appropriate prenatal surveillance and collaboration. The normal visit does not remove those ongoing risks.
Watch the distinction: Do not compress prenatal risk into a single high-risk or low-risk label. Each factor has a different mechanism and may change counseling, testing, or follow-up in a different way.
Reference: [1]
39. Counsel on nutrition and prevention in pregnancy
Pregnancy counseling connects intake and exposure to maternal health and fetal development. Assess what the patient can eat and drink, whether vomiting prevents fluids or medicines from staying down, and whether weight or hydration is changing. Nutritional discussion should cover a varied diet and relevant supplementation without assuming that a listed supplement replaces food. Review immunization history and pregnancy-specific recommendations through current guidance, since timing and suitability vary by vaccine. Ask directly and without judgment about tobacco, alcohol, other substances, and all medications, including nonprescription products, herbs, and supplements. Drug exposure depends on dose, timing, placental transfer, and the harm of leaving the underlying illness untreated. When vomiting is persistent or intake poor, assess severity and complications rather than offering only routine dietary tips. Document a concrete follow-up plan.
Worked example: At a prenatal visit, a patient reports several days of vomiting, little fluid intake, dark urine, and use of an over-the-counter sleep product. Assess hydration, weight change, ability to keep food and medicines down, and whether urgent treatment is needed. Review the product's ingredients and reason for use as part of medication reconciliation; its nonprescription status does not establish pregnancy safety.
Watch the distinction: Do not assume every nonprescription or herbal product is safe in pregnancy. Its active ingredients, dose, timing, and the condition being treated all affect the decision.
Reference: [1]
40. Interpret the prenatal examination
The prenatal examination interprets symptoms in the setting of gestational age and physiologic change. Ask about onset, severity, triggers, bleeding, fluid leakage, pain, breathing, and fetal movement when relevant. Measure vital signs and compare them with prior values rather than viewing a single reading in isolation. Examine the systems implicated by the complaint while assessing general appearance and stability. Mild reflux after meals can reflect pregnancy-related changes in gastrointestinal function, but chest pain, breathlessness, faintness, or abnormal vital signs require assessment for serious cardiopulmonary disease. Likewise, swelling or fatigue may occur in normal pregnancy yet can become concerning when sudden, severe, asymmetric, or paired with other symptoms. The decision sequence is to identify immediate danger, gather focused findings, then decide whether routine care, further testing, or urgent referral is appropriate.
Worked example: A patient at a prenatal visit describes brief burning discomfort after large meals and no breathing symptoms; her examination and vital signs are reassuring. Discuss a reflux pattern and follow-up if it changes. Another patient reports new chest pain and shortness of breath while walking across the room. Assess stability and arrange urgent evaluation rather than treating both complaints as ordinary reflux.
Watch the distinction: Do not use pregnancy as a blanket explanation for chest discomfort or breathlessness. The symptom pattern, functional change, vital signs, and examination determine urgency.
Reference: [1]
41. Explain prenatal genetic testing
Carrier screening asks whether a prospective parent carries a heritable variant that could affect offspring; it does not assess the chromosomes of the current fetus. Aneuploidy screening estimates the chance of a fetal chromosome condition using blood markers, cell-free DNA, or ultrasound findings. A structural finding on ultrasound may change that estimate or suggest a condition outside the screening panel. Diagnostic procedures obtain fetal or placental material for more definitive analysis, but the procedure and the laboratory test have distinct risks and limits. Start by asking what condition the patient wants information about, whether the result is a risk estimate or diagnosis, and what decisions the result could inform. A positive screen calls for counseling and an offer of diagnostic testing. The WHNP-BC candidate guide includes both prenatal screening and diagnostic testing in obstetric care.
Worked example: At 16 weeks, a patient receives a report calling a cell-free DNA screen high risk for a chromosome condition. An ultrasound has shown no structural finding. Explain that the screen raises the estimated chance but does not confirm fetal chromosomes; a normal ultrasound does not cancel it. Discuss genetic counseling, the available diagnostic procedure, its risks, and the patient's preference before any irreversible decision.
Watch the distinction: Calling a high-risk screen a fetal diagnosis skips the confirmatory step. Likewise, a low-risk result cannot exclude every genetic or structural condition, especially one the test never assessed.
Reference: [1]
42. Interpret fetal surveillance
Fetal surveillance combines measures that answer different questions. A nonstress test observes whether fetal heart rate accelerations accompany movement, offering a short-term view of autonomic responsiveness. Ultrasound assessment of amniotic fluid reflects a longer-running balance involving fetal urine production and placental function, although fluid volume has several possible causes. A biophysical profile adds observed movement, tone, breathing movements, and fluid assessment to the heart-rate component; a modified profile pairs the heart-rate test with fluid assessment. Interpret each component alongside gestational age, maternal illness, medications, and prior results. A reassuring tracing does not erase low fluid, and an initially nonreactive tracing may reflect fetal sleep or another reversible influence. Confirm the finding and arrange timely obstetric assessment when components disagree or the overall pattern raises concern.
Worked example: At a surveillance visit for a pregnancy with hypertension, the tracing shows appropriate accelerations, but ultrasound reports substantially reduced fluid compared with prior examinations. The tracing supports current heart-rate responsiveness; it does not explain the fluid change. Review membrane-rupture symptoms, dating, growth, and the scan's measurement, then arrange prompt obstetric review and further surveillance rather than declaring the entire assessment reassuring.
Watch the distinction: Treating one normal surveillance component as a pass for every fetal risk misses what the other components measure. Interpret discordance before deciding the next interval or action.
Reference: [1]
43. Assess fetal growth and pregnancy course
An estimated fetal weight is an ultrasound estimate, subject to measurement error and dependent on sound pregnancy dating. Growth assessment becomes stronger when comparable scans show a trajectory, especially alongside fluid volume and Doppler information when indicated. A small fetus may reflect constitutional size, inaccurate dates, or restricted growth; a large estimate also needs clinical context rather than an automatic treatment change. Multiple gestation adds questions about each fetus's growth and, where relevant, shared placental circulation. Presentation matters as birth approaches because it affects planning, while prolonged pregnancy changes the balance of surveillance and delivery decisions. Review prior measurements, maternal conditions, fetal movement, fluid, and the quality of dating before labeling an aberration. Concerning trends or associated findings warrant obstetric collaboration and a coordinated surveillance plan.
Worked example: A fetus is estimated at 1,150 g on one scan and 1,430 g four weeks later. The arithmetic increase is 280 g, or about 70 g per week, but those figures alone cannot establish normal growth because ultrasound estimates have error and gestational age matters. If the report also shows a falling growth percentile and reduced fluid, review dating and measurements promptly with the obstetric team.
Watch the distinction: A single small weight estimate is not proof of placental disease. Ignoring a falling serial trajectory because the latest estimate still increased also misreads growth.
Reference: [1]
44. Understand blood-group sensitization
An RhD-negative patient can form anti-D antibodies after exposure to RhD-positive red cells. The blood type identifies susceptibility; the antibody screen identifies whether detectable sensitization has occurred. In an unsensitized pregnancy, prevention focuses on identifying events and times when RhD immune globulin is indicated under the care plan. Once clinically significant immune antibodies are present, prevention cannot remove them. The task changes to identifying the antibody, reviewing prior affected pregnancies and paternal or fetal antigen information where appropriate, and arranging fetal risk assessment with obstetric specialists. A reported anti-D result must also be interpreted in light of recent immune globulin because passive antibody can appear on screening. Other red-cell antibodies may matter even when the patient is RhD-positive. Follow the laboratory interpretation and pregnancy history together.
Worked example: A pregnant patient is RhD-negative after a prior birth. Her current antibody screen is negative. She has no evidence of established sensitization, so assess the pregnancy history and prevention opportunities. If a later screen detects anti-D, first check whether she recently received RhD immune globulin and review the laboratory report; do not assume that every detected anti-D result proves immune alloimmunization.
Watch the distinction: RhD-negative blood type alone does not mean the fetus is affected. Conversely, giving preventive immune globulin does not treat an already established, clinically significant immune antibody.
Reference: [1]
45. Triage early pregnancy complications
Early bleeding and pain require two initial questions: is the patient stable, and where is the pregnancy? Syncope, shoulder pain, peritoneal signs, or heavy bleeding demand emergency assessment because ectopic pregnancy or hemorrhage can be life-threatening. A positive pregnancy test without a confirmed intrauterine pregnancy remains a pregnancy of unknown location. Serial quantitative human chorionic gonadotropin results and repeat transvaginal ultrasound can clarify the course, but one value cannot locate the pregnancy or prove viability. Pregnancy loss may be suggested by ultrasound and interval findings, using validated diagnostic criteria rather than an early equivocal scan. Trophoblastic disease enters the differential when bleeding, ultrasound appearance, and hormone findings are unusual; tissue and specialist assessment establish the diagnosis. Explain warning symptoms and ensure a reliable follow-up pathway.
Worked example: At an estimated six weeks, a patient has spotting and one-sided pain. The pregnancy test is positive, blood pressure is stable, and ultrasound shows no confirmed intrauterine pregnancy. Label the location unresolved, arrange serial testing and repeat imaging, and give explicit emergency precautions for worsening pain, dizziness, or heavy bleeding. The single hormone result cannot justify calling this a miscarriage or excluding an ectopic pregnancy.
Watch the distinction: A nondiagnostic early ultrasound does not prove that pregnancy has ended. Assuming ectopic pregnancy is excluded because pain is mild overlooks the possibility of later rupture.
Reference: [1]
46. Distinguish causes of later pregnancy bleeding
Later pregnancy bleeding is a maternal and fetal assessment problem before it is a labeling problem. Placenta previa involves placental tissue near or over the cervical opening and often presents with painless bleeding; ultrasound location guides precautions, including avoiding a digital cervical examination until previa is excluded. Abruption is premature placental separation and may produce pain, uterine tenderness, contractions, or fetal compromise; visible blood can underestimate loss. Placenta accreta spectrum means abnormal placental attachment, often suspected from imaging and a history of uterine surgery, and chiefly changes hemorrhage and birth planning. Vasa previa involves unprotected fetal vessels crossing near the cervical opening; bleeding after membrane rupture with fetal heart-rate deterioration is especially dangerous. Assess vital signs, bleeding, pain, contractions, fetal status, and placental information while arranging urgent obstetric care.
Worked example: At 31 weeks, a patient reports fresh painless bleeding. An earlier scan described a low-lying placenta. Check maternal stability and fetal status, obtain urgent obstetric evaluation, and avoid digital cervical examination while placental position is clarified. If the same patient instead has severe pain, a tender firm uterus, and concerning fetal status, abruption becomes a leading concern even if external bleeding appears modest.
Watch the distinction: Using pain alone to rule a placental condition in or out is unsafe. Previa and abruption have typical patterns, but hemorrhage severity and fetal status determine urgency.
Reference: [1]
47. Recognize threatened early birth
Threatened early birth has several mechanisms that require different assessments. Regular contractions become preterm labor when accompanied by cervical change; contractions alone may settle without progressive dilation. Cervical insufficiency is more consistent with painless cervical shortening or dilation, often with a relevant prior history. Membrane rupture can present as a gush or persistent leakage and raises infection and cord concerns even without contractions. Ask when symptoms began, whether fluid continues to leak, and whether there is bleeding, fever, or reduced fetal movement. Assess maternal and fetal status, contraction pattern, and the cervix using an approach suited to the suspected condition. When rupture is possible, a sterile speculum examination and appropriate testing help establish it; repeated digital examinations can increase infection risk. Prompt obstetric collaboration determines surveillance and treatment.
Worked example: At 29 weeks, a patient reports regular tightening and a continuous trickle of clear fluid. Maternal temperature is normal, but the symptoms still require prompt assessment. Evaluate fetal status and contractions, use a sterile speculum approach to assess possible membrane rupture, and arrange obstetric care. Cervical change would support labor; confirmed fluid leakage would add a separate management concern.
Watch the distinction: Contractions without documented cervical change do not by themselves establish preterm labor. Painless dilation or fluid leakage may threaten pregnancy even when contractions are absent.
Reference: [1]
48. Evaluate hypertensive pregnancy disorders
A blood-pressure reading gains meaning from its timing, repetition, prior baseline, and associated findings. Chronic hypertension predates pregnancy or is recognized early; new hypertension later in pregnancy prompts evaluation for a pregnancy-specific disorder. Protein in urine is useful, but serious disease can also appear through headache, visual symptoms, upper abdominal pain, low platelets, kidney dysfunction, liver injury, or pulmonary symptoms. Review measurement technique and repeat an unexpected reading without delaying assessment of a symptomatic patient. Compare platelet and chemistry results with earlier values, check urine protein using an appropriate measure, and assess fetal well-being. The WHNP's priority is to recognize possible progression, evaluate immediate safety, and coordinate urgent obstetric management when concerning symptoms or organ findings accompany hypertension.
Worked example: A patient with previously normal readings now has repeated elevated blood pressure, a persistent severe headache, and a platelet count that has fallen from her earlier result. Even before urine protein returns, this combination raises concern for worsening hypertensive disease. Assess symptoms and maternal-fetal status urgently, obtain relevant blood and urine studies, and arrange immediate obstetric evaluation.
Watch the distinction: Waiting for proteinuria before responding to headache and falling platelets can miss serious disease. One elevated reading also needs proper confirmation and context rather than automatic classification.
Reference: [1]
49. Manage metabolic and medical comorbidity
Medical conditions affect pregnancy through both maternal physiology and fetal exposure. Preexisting diabetes may carry risks from before conception, whereas gestational diabetes emerges during pregnancy; either calls for review of glucose patterns, nutrition, treatment, and growth findings together. Thyroid dysfunction can alter maternal symptoms and fetal development, so interpretation depends on the condition, treatment, and pregnancy context. Obesity modifies several obstetric risks but cannot substitute for individual assessment. Anemia requires attention to red-cell indices and likely cause rather than assuming every low hemoglobin reflects iron deficiency. Epilepsy management balances seizure prevention against medication exposure; abrupt withdrawal can create maternal and fetal danger. Reconcile the full medication list, review objective trends, and coordinate condition-specific care with the prenatal team. A single scan or isolated laboratory value rarely captures the whole risk picture.
Worked example: A patient with preexisting diabetes has rising fetal growth estimates on two scans, while her glucose log shows frequent high readings after meals. The paired trends support a focused review of meal patterns, measurements, and treatment with the obstetric diabetes team. One growth estimate alone would be too imprecise to justify a medication change, and normal fasting values would not erase the post-meal pattern.
Watch the distinction: Treating all diabetes first recognized in pregnancy as identical overlooks preexisting disease and its earlier exposure period. Likewise, stopping an antiseizure medicine abruptly can increase harm.
Reference: [1]
50. Recognize infection, clot, and mood risk
Pregnancy changes the consequences of common symptoms. Fever, urinary symptoms, respiratory illness, or genital infection require evaluation of maternal illness and possible fetal effects; site-specific testing and the clinical picture guide treatment. Pregnancy also raises thromboembolic risk. Unilateral leg swelling or pain followed by abrupt breathlessness, chest pain, or faintness warrants emergency assessment, even if anxiety is present. Substance exposure calls for a private, nonjudgmental history, attention to dependence and withdrawal risk, and support matched to the patient's goals. Perinatal mood assessment asks about function, sleep, support, self-harm thoughts, and symptoms of psychosis; immediate safety concerns take priority. Put urgency first, then investigate the likely mechanism and arrange continuing care. WHNP-BC practice questions can help rehearse these competing priorities.
Worked example: At 27 weeks, a patient reports a swollen painful left calf, then sudden shortness of breath and lightheadedness. Her history of panic attacks does not explain away a possible clot. Check immediate stability and arrange emergency evaluation for thromboembolism while communicating the symptom sequence and pregnancy status. Routine reassurance or a delayed outpatient leg assessment would miss the acute respiratory risk.
Watch the distinction: A familiar anxiety diagnosis does not exclude pulmonary embolism. Similarly, labeling fever or mood symptoms as ordinary pregnancy discomfort can delay care for infection or psychiatric emergency.
Reference: [1]
51. Support normal postpartum recovery
After birth, uterine contraction reduces bleeding and the uterus gradually involutes. Lochia normally changes in amount and character over time, so ask about trend, clots, odor, pain, and dizziness rather than judging one description alone. Lactogenesis depends on hormonal changes after placental delivery and frequent milk removal; feeding concerns call for assessment of latch, intake cues, and breast symptoms. Perineal recovery, bowel and bladder function, sleep, nutrition, and emotional adjustment also shape care. Breastfeeding can delay ovulation, but ovulation may precede the first menstrual period. Contraceptive counseling therefore begins with the patient's pregnancy goals, feeding plans, medical conditions, and desired method. Clarify what recovery changes are expected and which patterns, such as increasing bleeding, fever, or severe mood symptoms, need prompt assessment.
Worked example: Four weeks after birth, a breastfeeding patient has no menses and wants to avoid pregnancy. Explain that the first ovulation can occur before any visible period, so amenorrhea alone does not establish infertility. Review intercourse, feeding pattern, medical history, and preferences, then offer suitable contraception. Also ask about bleeding trend, pain, feeding, sleep, and mood during the same visit.
Watch the distinction: Assuming no period means no pregnancy risk can leave a patient without their chosen protection. Postpartum counseling should connect fertility, recovery, and feeding rather than treat them separately.
Reference: [1]
52. Triage postpartum complications
Postpartum symptoms are interpreted by severity, trajectory, and associated findings. Increasing bleeding, large clots, faintness, or a poorly contracted uterus raises hemorrhage concern. Fever with uterine tenderness or foul-smelling lochia suggests infection; focal breast redness, pain, and systemic symptoms point toward mastitis, while a persistent mass or unusual finding needs its own breast assessment. Difficulty voiding with lower abdominal fullness suggests retention, which can worsen uterine bleeding. A painful expanding perineal swelling may be a hematoma despite limited visible blood. Unilateral leg symptoms or sudden breathlessness raise clot concern. Severe mood disturbance, suicidality, or psychosis requires immediate safety assessment. Evaluate vital signs and stability first, then localize the likely source and arrange urgent or emergency care according to the findings. The breast care guide offers related breast assessment review.
Worked example: Five days after discharge, a patient reports much heavier bleeding than yesterday and feels dizzy on standing. This change warrants urgent maternal assessment for blood loss, not routine recovery advice. Another patient has fever and a localized hot, painful breast area with otherwise stable circulation; evaluate feeding, breast findings, and systemic illness promptly for possible mastitis and needed treatment.
Watch the distinction: Calling every postpartum bleed normal lochia ignores changes in volume and symptoms. Conversely, a focal painful breast with fever calls for targeted assessment, not an automatic hemorrhage pathway.
Reference: [1]
Pharmacology
53. Follow a drug through the body
Drug exposure follows absorption into the body, distribution among tissues, metabolism into products, and excretion. Route changes absorption: an oral drug faces gastrointestinal uptake and potentially first-pass metabolism, while an intravenous dose enters circulation directly. Protein binding and body water influence distribution; liver activity can alter metabolism; kidneys eliminate many drugs or metabolites. Pregnancy may change blood volume, renal filtration, and enzyme activity, but the direction and size of a change depend on the drug. Kidney impairment can reduce clearance and raise exposure even when the prescribed dose stays constant. Ask which step governs the drug's concentration and effect, then review renal and hepatic function, other medicines, response, and toxicity. Dose decisions require the particular drug's evidence and patient findings, not a universal pregnancy adjustment.
Worked example: A patient taking a hypothetical drug eliminated mainly unchanged in urine develops kidney impairment. If clearance falls while the same amount enters the body each day, drug may accumulate and adverse effects may appear. Review kidney results, timing of doses, symptoms, and any available drug-specific monitoring; coordinate a revised regimen if indicated. The unchanged prescription does not imply unchanged exposure.
Watch the distinction: Confusing dose with concentration overlooks clearance. A patient may receive the same milligrams yet experience a higher concentration when elimination slows or an interacting drug changes metabolism.
Reference: [1]
54. Calculate half-life and accumulation
Half-life is the time needed for drug concentration to fall by half during the elimination phase. For first-order elimination under stable conditions, the fraction remaining after n half-lives is (1/2)^n. This describes one dose after absorption and distribution have settled; it does not mean that repeated doses vanish before the next dose. With regular dosing, each new dose adds to residual drug, so concentrations rise toward a steady pattern as input and elimination balance. After roughly the same number of half-lives, a similar fraction of the eventual steady concentration has been reached or cleared, assuming kinetics remain stable. Changes in kidney or liver function can lengthen half-life and increase accumulation. Interpret the calculated fraction alongside dosing interval, therapeutic window, and any drug-specific monitoring.
Worked example: Assume a hypothetical drug has an 8-hour half-life, first-order elimination, and no further doses. After 32 hours, 32 ÷ 8 = 4 half-lives. The remaining fraction is (1/2)^4 = 1/16 = 0.0625, or 6.25% of the post-distribution amount. If dosing continues every 8 hours, residual drug remains when each dose arrives, so accumulation occurs.
Watch the distinction: Four half-lives do not mean zero drug remains. The 6.25% result applies to one dose under the stated assumptions, not automatically to a repeatedly dosed regimen.
Reference: [1]
55. Predict mechanism-based interactions
Drug interactions can change effect without changing concentration, or change concentration through pharmacokinetics. A pharmacodynamic interaction occurs when two agents influence the same physiologic outcome, such as additive bleeding or sedation. A pharmacokinetic interaction affects absorption, transport, metabolism, or elimination; an enzyme inhibitor may increase exposure to a drug it normally clears, while an inducer may reduce it. For a prodrug, however, inhibiting the activating enzyme may reduce active-drug formation, so the usual 'inhibitor means stronger effect' shortcut can fail. Start with each drug's purpose and mechanism, identify the shared outcome or affected pathway, then assess timing, organ function, and the observed response. Monitor for the clinically relevant harm or loss of benefit and use drug-specific evidence before altering treatment.
Worked example: A patient takes two medicines that each impair hemostasis and develops easy bruising. Their combined bleeding effect is plausible even if neither blood concentration changed. In a separate case, a new enzyme inhibitor is added to a drug cleared by that enzyme; exposure may rise. Review the exact pathway and clinical signs before deciding whether monitoring or a regimen change is needed.
Watch the distinction: Calling every interaction a concentration change misses additive clinical effects. Assuming enzyme inhibition always increases benefit also fails when an enzyme is needed to activate a prodrug.
Reference: [1]
56. Interpret pharmacogenetic information
Inherited enzyme variation can alter how quickly a drug is activated or cleared. A reduced-function variant may lower the effect of a prodrug that needs that enzyme, yet increase exposure to an active drug normally removed by the same pathway. Transporter and target variants can also affect response. A genotype result is therefore meaningful only with the specific drug, variant interpretation, dose, and clinical setting. Other medicines, pregnancy-related physiologic changes, kidney or liver function, and adherence may outweigh or modify the genetic effect. Distinguish an association from an actionable prescribing recommendation by checking drug-specific evidence and the patient's actual response. Explain the finding as one input to shared treatment planning, and document any change and its monitoring plan.
Worked example: Assume a hypothetical prodrug needs enzyme E to become active. A patient has a confirmed low-function E genotype and has shown little benefit despite taking the medicine as prescribed. Reduced activation is plausible, but first review the test interpretation, other drugs that inhibit E, and the condition being treated. Then consider an evidence-supported alternative and monitor response.
Watch the distinction: A genotype does not diagnose treatment failure by itself. The same low-function enzyme could reduce activation of one drug while increasing exposure to another drug it normally clears.
Reference: [1]
57. Balance benefit, contraindication, and monitoring
Treatment selection begins with a clear indication and the outcome that matters to the patient. Next separate contraindications, which can make an option unsuitable, from expected adverse effects that may be manageable with counseling or monitoring. Review prior serious reactions, pregnancy or lactation context, organ function, other drugs, and patient preferences. Compare plausible alternatives for effectiveness, burden, and reversibility, then define how response and harm will be checked. A symptom improving does not rule out a serious adverse effect, and a laboratory change needs interpretation against baseline and treatment purpose. When the condition or treatment exceeds the WHNP's setting or expertise, coordinate care while maintaining follow-up. Document the rationale, the patient's informed choice, and specific signs that should prompt reassessment.
Worked example: A patient needs treatment for an infection but previously had a severe immediate reaction to the proposed drug. Do not treat that history as an ordinary nausea warning. Verify the reaction and likely culprit, select an effective alternative supported for the infection and patient context, and explain expected benefits and adverse effects. Set a follow-up plan to confirm symptom improvement and address worsening illness.
Watch the distinction: Counseling cannot make a true serious contraindication acceptable. Equally, labeling every unpleasant but predictable effect an allergy may unnecessarily remove useful treatment options.
Reference: [1]
58. Assess medication use in pregnancy and lactation
Medication decisions in pregnancy compare the consequences of untreated disease with potential fetal exposure. Timing matters because organ formation, growth, and late fetal adaptation are different exposure windows. Placental passage depends on drug properties, yet passage alone does not establish harm. In lactation, milk concentration must be considered with the amount of milk consumed, infant absorption and clearance, infant age or illness, and the parent's need for treatment. A detectable drug in milk is evidence of transfer, not a complete risk assessment. Review the quality of human evidence, consider an effective option with suitable exposure data, and avoid abrupt withdrawal of a medicine that controls a serious condition. Explain uncertainty honestly and monitor both parent and infant for the effects relevant to the chosen therapy.
Worked example: A breastfeeding patient needs medication for a chronic condition, and a report says the drug is detectable in milk. Ask about infant age, prematurity, feeding volume, and known infant effects, then weigh these against the risk of leaving the parent's disease untreated. Choose a supported regimen with appropriate infant observation. Detection alone does not calculate the infant dose or prove clinical harm.
Watch the distinction: Treating any milk transfer as a reason to stop therapy ignores infant dose and untreated disease. Calling a drug safe solely because a short exposure caused no symptoms is equally weak.
Reference: [1]
Professional Practice Issues
59. Apply consent, confidentiality, and ethics
Informed consent is a continuing conversation about purpose, likely benefits, material risks, alternatives, and the option to decline. Assess whether the patient can understand, appreciate, reason about, and communicate a choice for the decision at hand. Respecting autonomy includes a capacitated refusal, while beneficence and harm prevention require explaining consequences and offering continuing care. Justice asks whether language, disability, cost, or bias is limiting access to a fair decision. Confidentiality supports candid reproductive and sexual health care, but consent and disclosure rules vary by jurisdiction and patient age; identify the applicable rule before promising absolute secrecy or disclosing information. Document the patient's understanding, questions, choice, and agreed follow-up. Consult the care team or legal resources when capacity, immediate safety, or a reporting obligation is uncertain.
Worked example: A patient declines a recommended diagnostic procedure after explaining its purpose, risks, and what might remain unknown without it. Confirm decision-making capacity, ask about concerns, discuss alternatives and warning symptoms, and document the informed refusal and follow-up plan. If the patient is a minor or disclosure is requested by someone else, apply the governing jurisdiction's consent and confidentiality rules before sharing information.
Watch the distinction: A signature alone does not prove informed consent, and refusal does not end the clinician's duty to explain risk and offer follow-up. Confidentiality also has jurisdiction-specific limits.
Reference: [1]
60. Use evidence to improve safety
Reliability asks whether a measure gives consistent results; validity asks whether it measures what it claims to measure. A highly reliable reminder log may consistently count messages sent yet fail to measure whether patients received or understood them. Statistical significance addresses whether an observed difference is unlikely under a stated null model; it does not establish clinical importance or causation. Before applying a study or clinic result, check who was included, whether comparison groups differed, whether data were complete, and whether the outcome matters to patients. Quality improvement then uses a defined measure, team communication, a planned change, and repeated review over time. Investigate unintended effects, such as more reminders reaching one language group than another, and revise the workflow when results or equity warrant it.
Worked example: A clinic recorded 24 missed follow-ups among 120 appointments before reminders and 12 among 120 afterward. Rates are 24 ÷ 120 = 20% and 12 ÷ 120 = 10%, a 10 percentage-point decrease. Before crediting reminders, check whether appointment types and data capture were comparable. Continue tracking the rate over successive periods and confirm that completed follow-ups improved.
Watch the distinction: A lower rate after an intervention does not alone prove the intervention caused it. A small p-value cannot repair biased comparison groups or show that the outcome matters clinically.
Reference: [1]